Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

327 ARTÍCULOS , VIENDO DEL 286 AL 300

What should we do if we were wrong and Alzheimer was right?

Breitner JC.

Int Psychogeriatr. 2014 Jan;26(1):3-6. doi: 10.1017/S1041610213001749. Epub 2013 Oct 18.

[Informed consent to the insertion of a PEG tube in a 53-year-old male patient with highly advanced dementia]

Roden C.

Wien Med Wochenschr. 2014 May;164(9-10):167-71. doi: 10.1007/s10354-013-0245-x. Epub 2013 Oct 25.

[Foreign body aspiration. An occasional finding in patients with dementia?]

Trevino-Peinado C, Paramo M, García del Barrio L, Riverol M.

Rev Clin Esp (Barc). 2014 Apr;214(3):e33. doi: 10.1016/j.rce.2013.09.007. Epub 2013 Oct 27.

Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial

Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE.

Int Psychogeriatr. 2014 Feb;26(2):239-46. doi: 10.1017/S1041610213001762. Epub 2013 Oct 29.

PET radiotracers for imaging P-glycoprotein: the challenge for early diagnosis in AD

Leopoldo M, Contino M, Berardi F, Perrone R, Colabufo NA.

ChemMedChem. 2014 Jan;9(1):38-42. doi: 10.1002/cmdc.201300362. Epub 2013 Oct 31.

Role for the neurexin-neuroligin complex in Alzheimer's disease

Sindi IA, Tannenberg RK, Dodd PR.

Neurobiol Aging. 2014 Apr;35(4):746-56. doi: 10.1016/j.neurobiolaging.2013.09.032. Epub 2013 Nov 6.

N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as BACE1 inhibitors: a patent evaluation of WO2013041499

Dessolin J.

Expert Opin Ther Pat. 2014 Feb;24(2):239-42. doi: 10.1517/13543776.2014.859246. Epub 2013 Nov 13.

Effects of a non-focal plasticity protocol on apathy in moderate Alzheimer's disease: a randomized, double-blind, sham-controlled trial

Suemoto CK, Apolinario D, Nakamura-Palacios EM, Lopes L, Leite RE, Sales MC, Nitrini R, Brucki SM, Morillo LS, Magaldi RM, Fregni F.

Brain Stimul. 2014 Mar-Apr;7(2):308-13. doi: 10.1016/j.brs.2013.10.003. Epub 2013 Oct 25.

In vivo optical signatures of neuronal death in a mouse model of Alzheimer's disease

Lin AJ, Castello NA, Lee G, Green KN, Durkin AJ, Choi B, LaFerla F, Tromberg BJ.

Lasers Surg Med. 2014 Jan;46(1):27-33. doi: 10.1002/lsm.22206. Epub 2013 Nov 28.

Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus

Rinne JO, Frantzen J, Leinonen V, Lonnrot K, Laakso A, Virtanen KA, Solin O, Kotkansalo A, Koivisto A, Sajanti J, Karppinen A, Lehto H, Rummukainen J, Buckley C, Smith A, Jones PA, Sherwin P, Farrar G, McLain R, Kailajarvi M, Grachev ID.

Neurodegener Dis. 2014;13(4):237-45. doi: 10.1159/000355256. Epub 2013 Nov 27.

The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective

Whitehouse PJ.

Biochem Pharmacol. 2014 Apr 15;88(4):677-81. doi: 10.1016/j.bcp.2013.11.017. Epub 2013 Dec 1.

Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque

Holland JP, Liang SH, Rotstein BH, Collier TL, Stephenson NA, Greguric I, Vasdev N.

J Labelled Comp Radiopharm. 2014 Apr;57(4):323-31. doi: 10.1002/jlcr.3158. Epub 2013 Dec 11.

Measuring life space in older adults with mild-to-moderate Alzheimer's disease using mobile phone GPS

Tung JY, Rose RV, Gammada E, Lam I, Roy EA, Black SE, Poupart P.

Gerontology. 2014;60(2):154-62. doi: 10.1159/000355669. Epub 2013 Dec 12.

Genetic mouse models of brain ageing and Alzheimer's disease

Bilkei-Gorzo A.

Pharmacol Ther. 2014 May;142(2):244-57. doi: 10.1016/j.pharmthera.2013.12.009. Epub 2013 Dec 19.

[Prevalence of anosognosia in Alzheimer's disease]

Turró-Garriga O, Conde-Sala JL, Reñé-Ramírez R, López-Pousa S, Gascón-Bayarri J, Garre-Olmo J.

Med Clin (Barc). 2014 Jul 7;143(1):13-9. doi: 10.1016/j.medcli.2013.04.043. Epub 2013 Jul 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias